4//SEC Filing
BOLGER JOHN C 4
Accession 0001209191-22-033477
CIK 0001674930other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:02 PM ET
Size
15.7 KB
Accession
0001209191-22-033477
Insider Transaction Report
Form 4
BOLGER JOHN C
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-05-31−313→ 0 totalExercise: $3.92Exp: 2028-05-18→ Common Stock (313 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-31−313→ 1,250 totalExercise: $5.81Exp: 2029-05-30→ Common Stock (313 underlying) - Exercise/Conversion
Common Stock
2022-05-31$3.92/sh+313$1,229→ 4,313 total - Exercise/Conversion
Common Stock
2022-05-31$5.81/sh+313$1,818→ 4,313 total - Sale
Common Stock
2022-05-31$55.25/sh−500$27,625→ 3,500 total - Sale
Common Stock
2022-05-31$55.32/sh−313$17,315→ 4,000 total - Sale
Common Stock
2022-05-31$55.44/sh−313$17,351→ 4,000 total
Footnotes (2)
- [F1]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001183863
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:02 PM ET
- Size
- 15.7 KB